BiotechTube
Home/Velorum Therapeutics/David Hitt
DH

David Hitt

Legal & Intellectual Property

Velorum Therapeutics

Therapeutic Areas

OncologyHematologyKidney disease

Velorum Therapeutics Pipeline

DrugIndicationPhase
Velorum-PPXErythropoietic Protoporphyria (EPP) / X‑linked Protoporphyria (XLP)Preclinical
Velorum-HemeSequesterCancer / Kidney injury / HemolysisPreclinical

Leadership Team at Velorum Therapeutics

PM
Parsa Modareszadeh
Co‑founder & President
PM
Pouya Modareszadeh
Co‑founder & CEO
RS
Richard Showalter
VP of Research & Development
HJ
Harri Järveläinen
Preclinical and Translational Sciences
LR
Lucas Rodriguez
Business Development
View full Velorum Therapeutics profile